SCHEMBL6189547

SCHEMBL6189547

CC(C)(C)OC(=O)NCc1cccc(C(O)c2cc(Cl)ccc2NCc2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.41
CTSL P07711 1/20 0.41
GAA P10253 1/20 0.41
HDAC1 Q13547 1/20 0.40
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
UTS2R Q9UKP6 1/20 0.39
GLS O94925 3/20 0.39
CTSK P43235 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA7 P43166 1/20 0.38
CA14 Q9ULX7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6191680 0.94 GAA (0.41) MRGPRX4CTSLGAAHDAC1LMNA
SCHEMBL6188662 0.93 GAA (0.40) MRGPRX4CTSLGAAHDAC1GLS
SCHEMBL6188620 0.91 HPGD (0.40) GAAHDAC1LMNACYP1A2CYP3A4
SCHEMBL6190392 0.90 MEN1 (0.43) GAAHDAC1LMNAMAPTCYP2C9
SCHEMBL6188238 0.88 HDAC1 (0.47) CTSLGAAHDAC1HTTCTSK
SCHEMBL6189178 0.88 PTGER1 (0.43) GAALMNAMAPTCYP2C9
SCHEMBL6190235 0.88 CTSL (0.39) CTSLGAAHDAC1LMNACYP1A2
SCHEMBL6188764 0.88 SMN1; SMN2 (0.41) LMNAMAPTHTTNPSR1GLS
SCHEMBL6188321 0.86 GLS (0.38) CTSLGAAHDAC1LMNACYP3A4
SCHEMBL6190238 0.86 GLS (0.38) CTSLGAAHDAC1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0979227-B1 4,1-BENZOXAZEPINES, THEIR ANALOGUES, AND THEIR USE AS SOMATOSTATIN AGONISTS TAKEDA PHARMACEUTICAL (JP) 2005-11-16 EP disclosed
US-6352982-B1 TREATING DIABETES, OBESITY, OR INVETERATE DIARRHEA IN A MAMMAL WHICH COMPRISES ADMINISTERING AN EFFECTIVE AMOUNT OF A COMPOUND OF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-03-05 US disclosed
CN-1252795-A 4, 1-benzoxazepine *, their analogs and their use as somatostatin agonists TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2000-05-10 CN disclosed
EP-0979227-A1 4,1-BENZOXAZEPINES, THEIR ANALOGUES, AND THEIR USE AS SOMATOSTATIN AGONISTS Takeda Chemical Industries, Ltd. (JP) 2000-02-16 EP disclosed
WO-1998047882-A1 4,1-BENZOXAZEPINES, THEIR ANALOGUES, AND THEIR USE AS SOMATOSTATIN AGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-10-29 WO disclosed